Oral budesonide is used to treat the following conditions with inflammation as a symptom: eosinophilic esophagitis (EoE); active, mild to moderate Crohn's disease (CD); active, mild to moderate ulcerative colitis; and primary immunoglobulin A nephropathy (IgAN) to reduce the loss of kidney function.
Budesonide is used to treat mild to moderate active Crohn's disease, an inflammatory bowel disease. This medicine works inside the intestines (bowels) to reduce inflammation and symptoms of the disease.
Budesonide is given by metered-dose inhaler or nebulizer for maintenance and prophylactic treatment of asthma, including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction. [23]
Budesonide (Entocort EC) is used to treat Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) in adults and children 8 years of age and older.
Budesonide is a prescription medication used for the treatment of Crohn’s disease, ulcerative colitis, and primary immunoglobulin A-type nephropathy. Budesonide is available under the following different brand names: Entocort EC, Uceris, Ortikos, Tarpeyo
Overview: Budesonide is used to treat ulcerative colitis or Crohn’s disease. It is a corticosteroid and works by reducing inflammation. Common side effects include headache, nausea, vomiting, and...
Budesonide is a corticosteroid medication commonly used to manage conditions such as asthma, chronic obstructive pulmonary disease (COPD), and inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. It works by reducing inflammation in the body.
Budesonide is a corticosteroid used to treat Crohn's disease, asthma, COPD, hay fever and allergies, and ulcerative colitis.